Farcast Biosciences India Profile
Key Indicators
- Authorised Capital ₹ 31.00 Cr
- Paid Up Capital ₹ 31.00 Cr
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 101.70%
- Profit Growth 73.39%
- Ebitda 76.30%
- Net Worth -15.57%
- Total Assets -12.60%
About Farcast Biosciences India
Farcast Biosciences India Private Limited (FBIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 18 May 2016 (Eight years and nine months 5 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Mitra Rxdx India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 31.00 Cr and a paid-up capital of Rs 31.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Farcast Biosciences India Private Limited India is Poornima Hegade as COMPANY SECRETARY. Mohit Malhotra and Satish Sankaran serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2016FTC093387
- Company No.
093387
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
18 May 2016
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Farcast Biosciences India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Poornima Hegade | Company Secretary | 17-Apr-2019 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Malhotra  | Director | 28-May-2020 | Current |
| Satish Sankaran | Director | 30-May-2020 | Current |
Financial Performance of Farcast Biosciences India.
Farcast Biosciences India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 101.7% increase. The company also saw a substantial improvement in profitability, with a 73.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Farcast Biosciences India?
In 2022, Farcast Biosciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Farcast Biosciences India?
Farcast Biosciences India has a workforce of 30 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Farcast Biosciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farcast Biosciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
